BorgWarner (BWA) vice president awarded 17,640 restricted shares in 2026 Form 4 filing

Rhea-AI Filing Summary

BorgWarner Inc. vice president Isabelle McKenzie received a grant of 17,640 shares of common stock as restricted stock on February 3, 2026. The award was granted for no cash consideration and increased her beneficial ownership to 61,195 shares held directly.

The restricted shares vest over time, with 50% scheduled to vest on February 28, 2028 and the remainder on February 28, 2029. This structure is typical of equity-based compensation designed to align an executive’s interests with the company’s longer-term performance.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McKenzie Isabelle

(Last) (First) (Middle)

3850 HAMLIN ROAD

(Street)

AUBURN HILLS MI 48326

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BORGWARNER INC [ BWA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Vice President

3. Date of Earliest Transaction (Month/Day/Year)
02/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/03/2026		A		17,640(1)	A	$0.0000(2)	61,195	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock award granted on 2/3/2026; shares will vest 50% on February 28, 2028 and 100% on February 28, 2029.

2. The restricted stock was granted for no consideration.

	Miyuki P. Oshima as attorney-in-fact for Isabelle McKenzie	02/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did BorgWarner (BWA) report for Isabelle McKenzie?

BorgWarner reported that vice president Isabelle McKenzie received a grant of 17,640 shares of BorgWarner common stock as restricted stock on February 3, 2026. This equity award was part of her compensation and involved no cash purchase price.

How many BorgWarner (BWA) shares does Isabelle McKenzie own after this Form 4?

After the restricted stock grant, Isabelle McKenzie beneficially owns 61,195 shares of BorgWarner common stock directly. This total reflects the newly granted 17,640 restricted shares reported in the Form 4 insider transaction filing dated February 3, 2026.

What are the vesting terms of Isabelle McKenzie’s restricted stock at BorgWarner (BWA)?

The 17,640 restricted shares granted to Isabelle McKenzie vest over time. 50% of the award vests on February 28, 2028, and the remaining 50% vests on February 28, 2029, encouraging longer-term retention and alignment with company performance.

Did Isabelle McKenzie pay for the restricted BorgWarner (BWA) shares reported on Form 4?

No, the filing states the restricted stock was granted for no consideration, with a reported price per share of $0.0000. This means the 17,640 restricted shares were awarded as compensation rather than purchased in an open-market or private transaction.

What role does Isabelle McKenzie hold at BorgWarner (BWA) in this Form 4 filing?

In this Form 4, Isabelle McKenzie is identified as an officer of BorgWarner with the title Vice President. The reported transaction reflects equity compensation tied to her executive position, rather than a discretionary open-market trade.